Decreased Vascular Permeability [PE] - N0000010252
Pharmacologic Class Information
Pharmacologic Code | N0000010252 |
Pharmacologic Name | Decreased Vascular Permeability |
Pharmacologic Uses |
|
Pharmacologic Concept | Physiologic Effects - [PE] |
Pharmacologic Concept Description | This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept. |
NDC Products with Decreased Vascular Permeability
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Decreased Vascular Permeability [PE].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
42227-081 | Cinryze | Non-Proprietary Name: Human C1-esterase Inhibitor | Injection, Powder, Lyophilized, For Solution | Intravenous | Takeda Pharmaceuticals America, Inc. | ACTIVE |